Alexion Pharmaceuticals (ALXN) PT Lowered to $161 at Deutsche Bank Following 4Q Report
Tweet Send to a Friend
Deutsche Bank lowered its price target on Alexion Pharmaceuticals (NASDAQ: ALXN) to $161.00 (from $163.00) while maintaining a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
